IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Giulia Tamponi et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 13: immune features of healthy rectal mucosa as predictors of invasion risk in stage II rectal cancerGiorgio Rivella, Michele Antoniutti, Melania Scarpa et al.|British journal of surgery|2025Cited by 0
Familial colorectal cancer history is associated with an altered immune–genomic profile in microsatellite-stable rectal cancer: a prospective multicentre cohort studySilvia Negro, Monica Ortenzi, Melania Scarpa et al.|SSRN Electronic Journal|2026Cited by 0
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?—The IMMUNOREACT 20 StudyLorenzo Dell’Atti, Mario Guerrieri, Andromachi Kotsafti et al.|Cancers|2026Cited by 0